Interview with Ali Akyildiz, General Manager, IMS Health Turkey
Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey.…
IMS Health Turkey
Last updated: 13.02.2014
Address: Gazeteciler Mahallesi, Yazarlar Lokak – No. 8, 34394 Esentepe – Sisli. Istanbul. Turkey
Tel: 90 212 355 5700
Company description
IMS is a leading provider of information, services and technology for the healthcare industry, covering markets in 100+ countries around the world.
A market leader for more than 55 years, we blend industry expertise and advanced technology to deliver the most accurate perspectives and in-depth analytics on healthcare dynamics. Actionable insights, powered by superior information assets, are tuned to our clients’ precise requirements.
We continuously innovate to keep pace with a global healthcare environment that is increasingly complex and interdependent. Whether our clients are decision makers in life sciences, payers, providers or policymakers, our analytical, commercial services and consulting capabilities are key to competitive advantage — and to achieving high-quality, cost-effective healthcare.
Products and services
Healthcare Measurement
Analytics & Services
Consulting
Interviews
Related
SeokHoon Kang – General Manager Turkey, Celltrion Healthcare
Best known as the company that launched the world’s first “antibody biosimilar,” Celltrion is looking to…
Evren Özlu – General Manager, Boehringer Ingelheim Turkey
Evren Özlü, General Manager of Turkey and Sub-Saharan Africa at Boehringer Ingelheim, discusses the company’s…
Ufuk Kumrulu – Chairman, Polifarma
Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu,…
Turkey / A Pharma Talent Hotbed
Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has…
Burak Dağlıoğlu – President, Investment Office of the Presidency of the…
The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines…
Muzzafer Bal – CEO, Ali Raif
Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a…
Turkey / Abdi Ibrahim CEO Talks Biosimilars, M&A, & US Entry
Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s…
Hatice Öncel – CEO, Ilko Pharmaceuticals
Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel…
Hamdi Akan – Head of the Executive Board, Clinical Research Association,…
Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and…
Ismail Yormaz – VP & Regional Director South-East, Recordati
Ismail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has…
Turkey / How Pricing is Straining Turkish Pharma’s Sustainability
Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of…
Şeyda Atadan Memiş – General Manager, Takeda Turkey
Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey…
